ReviewFrontiers in immunology2025

The innate immune response in SARS-CoV2 infection: focus on toll-like receptor 4 in severe disease outcomes.

Enrico Maggi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.